High-dose interleukin-2 (HD IL-2) for metastatic renal Cell carcinoma (mRCC): Contemporary utilization trends in the United States. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Allard, Christopher
  • Gelpi-Hammerschmidt, Francisco
  • Harshman, Lauren Christine
  • Faiena, Izak
  • Modi, Parth K
  • Chung, Benjamin I
  • Singer, Eric A
  • Chang, Steven L

publication date

  • March 1, 2015